コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 sponse rates at different AD thresholds were calculated and were expressed as the percentage of completely responding BMs
2 esent the cumulative average intake across the 5 exams, and were expressed as percentile categories of intake (<=15th, >1
3 ned by ELISA or tandem mass spectrometry, respectively, and were expressed as median (25 - 75% range, mug/mmol creatinine
4 c inverse-variance method with random effects weighting and were expressed as mean differences (MDs) or standardized mean
6 Thirty of the most immunodominant B. microti antigens were expressed as recombinant proteins in E. coli.
9 JKH-C7 and the receptor-blocking VHH class (JIK-B8) were expressed as a heterodimeric VHH-based neutralizing agen
10 Recipient CD154+TcM induced by stimulation with donor cells were expressed as a fraction of those induced by HLA nonident
12 rent treatments, weight loss, colour and acrylamide changes were expressed as a function of the thermal effect received b
13 eavy and light chain cDNAs from dominant plasmablast clones were expressed as mAbs and used to purify antigens by using i
14 -sensitivity C-reactive protein (hsCRP) serum concentration were expressed as mean differences (MDs) and 95% confidence i
19 Using cerebellar gray reference, 18F-T807 data were expressed as standardized uptake value ratio, and 11C-Pi
21 The estimates of the intervention effects were expressed as the mean differences in percentages or mill
23 rming growth factor-alpha (TGF-alpha) and epiregulin (EPRG) were expressed as FimH fusion proteins on the surface of E. c
24 d brain measures as outcome variables, and effect estimates were expressed as standardized beta values.
25 Random-effects NMA was performed and summary estimates were expressed as odds ratio and 95% confidence intervals (OR
26 ) bivariate analyses were done and risk factors for illness were expressed as matched odds ratios and odds ratios (unmatc
28 plasma, three previously described neutralizing murine mAbs were expressed as mouse-human chimeric antibodies and evaluat
34 tive risks, comparing patients to the background population were expressed as standardized incidence ratios (SIRs) and st
35 Differences in cumulative ongoing pregnancy rates were expressed as a fecundity rate ratio with 95% CI, calcula
43 es, and entropies of adsorbed species and transition states were expressed as a function of surface coverage of the most
44 The results of the pulmonary function tests were expressed as the percentage of predicted values and were
48 including weight, height, and body mass index (BMI), which were expressed as Z scores: weight-for-age, height-for-age an
49 Kv1.3-Kv1.5 channels and point-mutant Kv1.3 channels, which were expressed as GFP- or cherry-fusion proteins.
50 n in a manner that agreed with the model predictions, which were expressed as dose-signaling response curves.